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Abstract
Panobinostat, a pan-deacetylase inhibitor, represents a novel therapeutic option for cancer diseases. Besides its
ability to block histone deacetylases (HDACs) by promoting histone hyperacetylation, panobinostat interferes with
several cell death pathways providing a potential efficacy against tumors. We have previously demonstrated that
panobinostat has a potent apoptotic activity in vitro and causes a significant growth delay of hepatocellular carci-
noma (HCC) tumor xenografts in nude mice models. Here, we show that treatment with panobinostat is able to
induce noncanonical apoptotic cell death in HepG2 and in Hep3B cells, involving the endoplasmic reticulum (ER)
stress by up-regulation of the molecular chaperone binding immunoglobulin protein/glucose-regulated protein 78,
activation of eukaryotic initiation factor 2α–activating transcription factor 4 (tax-responsive enhancer element B67)
and inositol requiring 1α–X-box binding protein 1 factors, strong increase and nuclear translocation of the transcrip-
tion factor C/EBP homologous protein/growth arrest and DNA damage–inducible gene 153, and involvement of c-Jun
N-terminal kinase. These signaling cascades culminate into the activation of the ER-located caspase-4/12 and of
executioner caspases, which finally lead to cell demise. Our results clearly show that panobinostat induces an alternative
ER stress–mediated cell death pathway in HCC cells, independent of the p53 status.
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Introduction
Hepatocellular carcinoma (HCC) represents one of the most com-
mon malignancies worldwide and its treatment options still remain
limited, especially in patients with compromised liver function. A
multitude of different signaling pathways is altered in liver cancer
cells and dysregulation of the balance between proliferation and cell
death contributes to hepatocarcinogenesis [1].
Deacetylase inhibitors (DACis), a novel class of compounds, have
shown strong antitumor activity in preclinical studies and are currently
investigated in clinical trials for treatment of several blood and solid
malignancies [2]. These compounds are able to induce cell death, cell
differentiation, and/or cell cycle arrest in many different cancer models,
through inhibition of enzymes involved in deacetylation of histones and
other proteins, which promotes the re-expression of tumor suppressor
genes [3].
Recent reports suggest that DACis can also induce accumulation
of misfolded proteins and trigger endoplasmic reticulum (ER) stress–
induced cell death in tumor cells by interfering with nonhistone pro-
teins [4–7]. In particular, it has been shown that vorinostat (SAHA)
is able to activate atypical ER stress–related apoptosis, acting as ER
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stress mediator and apoptosis enhancer in oral squamous cell carcinoma
and brain and prostate cancer models [6,7].
Panobinostat (LBH589), a cinnamic hydroxamic acid, is a novel
pan-DACi that has shown potent antitumor activity in preclinical
models and clinical trials [2,3,8,9].
We have previously demonstrated that panobinostat treatment was
able to block cell proliferation in human HCC cell lines and to induce
DNA damage and cell death in vitro and in subcutaneous xenograft
models, independent of canonical intrinsic and/or extrinsic apoptotic
pathways, which was probably mediated by alternative death mecha-
nisms, like ER stress–induced apoptosis [10].
ER stress is a highly conserved cellular defense mechanism that
responds to perturbations of ER function [11,12]. Factors that alter
ER homeostasis, e.g., massive increase of protein synthesis, alteration
of protein maturation mechanisms, decreased chaperone function,
and alterations in calcium stores in the ER lumen, contribute to
ER stress, resulting in a massive accumulation of unfolded/misfolded
proteins [4,13,14].
As an initial response to ER stress, cells activate a cascade of recovery
actions, named collectively unfolded protein response (UPR), that
communicate information about protein-folding status to the nucleus,
giving a prompt response to raise protein folding capacity, degrade
misfolded proteins, and decrease de novo protein synthesis [14,15].
UPR is mediated by three distinct signaling pathways initiated by
the ER-transmembrane transducers inositol requiring 1α (IRE1α),
PKR-like ER kinase (PERK), and activating transcription factor
(ATF) 6α [14–16], which are maintained in an inactive state through
association with the ER chaperone binding immunoglobulin protein
(BiP) in resting cells. Due to massive prolonged or unresolved ER
stress, the accumulation of unfolded proteins leads to BiP dissociation
and activation of the three ER stress sensors, triggering the UPR, a
prosurvival cellular response that aims to reduce the huge mass of
unfolded proteins and to overcome the effects of ER stress [17]. How-
ever, if the stress cannot be resolved, this adaptive process switches
to a proapoptotic response, leading to elimination of cells unable to
handle the unfolded protein accumulation through the UPR inter-
vention [17–19].
The complete mechanisms promoting ER stress–induced cell death
still remain unclear. However, it has been demonstrated that several
other apoptosis mediators, like the transcription factor C/EBP homol-
ogous protein (CHOP), the mitogen-activated protein kinase c-Jun
N-terminal kinase (JNK), and B-cell lymphoma 2 (Bcl-2) family pro-
teins, are involved in ER stress–associated cell death and activated
through the above-mentioned upstream factors [15,18]. The activation
of these factors can promote the expression of cell death–related genes
and/or modulate the activation of ER stress–sensible executioner
caspases, like caspase-4/12, leading to apoptotic cell death.
Here, we investigate the ability of the pan-DACi panobinostat
to activate ER stress–related apoptotic cell death in HCC cell lines,
supporting the impact of alternative cell death pathways as potential
new targets for cancer therapy and confirming the use of this com-
pound as a promising anticancer drug.
Materials and Methods
Cell Culture and Reagents
Human HCC cell lines HepG2 (TP53wt) and Hep3B (TP53null)
were cultured under standard conditions as previously described [10].
Cells were treated with 0.1 μM panobinostat (LBH589) and analyzed
or processed for further experiments from 6 to 72 hours. Panobinostat
was kindly provided by Novartis Pharma AG (Basel, Switzerland) and
prepared as previously described [10]. Thapsigargin and SP600125
were purchased from Sigma-Aldrich (Munich, Germany) and dissolved
in DMSO (Sigma-Aldrich).
Quantitative and Semiquantitative Reverse
Transcription–Polymerase Chain Reaction
For semiquantitative polymerase chain reaction (PCR) and quan-
titative real-time PCR, total cellular RNA was extracted using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manu-
facturer’s instructions and reverse transcription (RT) was performed
with Quantitect Reverse Transcription Kit (Qiagen). For semiquanti-
tative PCR, the Ready Mix Taq PCR Kit (Sigma-Aldrich) was used.
The oligonucleotides 5′-CCTTGTAGTTGAGAACCAGG-3′ and
5′-GGGGCTTGGTATATATGTGG-3′ (Eurofins MWG Operon,
Ebersberg, Germany) were used for amplification of the X-box binding
protein 1 (XBP-1) transcript fragments. PCR products were resolved
on two different 2% agarose gels, stained with Sybersafe DNA gel
stain (Life Technologies, Darmstadt, Germany) and visualized under
ultraviolet illumination using Fusion image capture (PEQLAB Biotech-
nologie GmbH, Erlangen, Germany). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was amplified as an internal control.
For quantitative real-time PCR, QuantiTect Primers for IRE1α,
IRE1β, BiP, ATF4, CHOP, and GAPDH were purchased from
Qiagen and run with the QuantiFast SYBR Green PCR Kit (Qiagen)
on a CFX96 Real-Time PCR Detection System (Bio-Rad, Munich,
Germany). Results were analyzed with the CFX Manager v2.0 and
Rest 2008 software and normalized to GAPDH mRNA content for
each sample.
CHOP Transcript Modulation
siRNAs against CHOP Hs_DDIT3_1, _2, _3, and _5 were pur-
chased from Qiagen. Transfection was performed with HiPerfect
(Qiagen) following the Qiagen Fast Transfection Protocol as described
by the company. Hs_DDIT3_1 siRNA showed the best transfection
efficiency in both HCC cell lines and it was used for the following
experiments. AllStars Negative Control (Qiagen) oligonucleotide was
used as nonsilencing control.
Real-time Cell Viability Analysis
The xCELLigence RTCA SP System (Roche Applied Science,
Mannheim, Germany) was used for real-time analysis of the cellular
response of HepG2 and Hep3B cells following incubation with
0.1 μM panobinostat and SP600125 (100 nM and 10 μM) and trans-
fection with CHOP siRNA as previously described [20]. Cell index,
indicating attachment and adherence of cells to the plate’s electrode,
was measured for the following 70 hours continuously. Data analysis
was performed using the RTCA Software v1.2.1.
Immunofluorescence
HepG2 and Hep3B cells were seeded in chamber slides (Lab Tek dis-
tributed by Fisher Scientific GmbH, Schwerte, Germany) and treated
with 0.1 μMpanobinostat and 10 nM thapsigargin for 24 and 48 hours.
Immunofluorescence was performed as previously described [20]. Pri-
mary antibodies against BiP, ATF4, IRE1α, S724-IRE1α, and CHOP
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were purchased from Abcam (Cambridge, United Kingdom) and
secondary Alexa Fluor 488– and 568–conjugated antibodies from Life
Technologies. The fluorescence was visualized with a Nikon microscope
at ×630 magnification and acquired with a Hamamatsu ORCA-ER
camera (model C4742-80) under the same setting. Obtained data were
analyzed with ImageJ software v 1.43u. The quantification of the
fluorescence signals was performed using the image processing software
Photoshop from Adobe with the background-corrected fluorescence
methods as described before [21].
Protein Extraction and Western Blot Analysis
Whole-cell lysates were obtained from HepG2 and Hep3B cell lines
with or without treatment with panobinostat after 6 to 72 hours, and
10 nM thapsigargin after 24 hours, and further processed by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis followed byWestern
blot analysis, as previously described [20]. Immunodetection was
performed with primary antibodies against BiP, eukaryotic initiation
factor 2α (eIF2α), S51-eIF2α (Abcam), and β-actin (Sigma-Aldrich).
Secondary HRP-conjugated antibodies (Sigma-Aldrich) were detected
by incubating the immunoblots with SuperSignal West Pico Chemi-
luminescent Substrate (Pierce, Thermo Fisher Scientific). The lumi-
nescent reactivity was measured by using Fusion image capture and
further quantified with Bio1D Analysis System (PEQLAB Biotech-
nologie GmbH). Anti–β-actin was used to control equal loading and
protein quality.
Caspase Activity Assays
Caspase activity assays were performed as previously described
[10] using Caspase Glo-8 and Caspase Glo-3/7 Luminescent Assays
(both from Promega GmbH, Mannheim, Germany) or Caspase-12
and Caspase-4 Fluorometric Assay Kits (Biovision, Mountain View,
CA) according to the manufacturer’s protocol and GloMax 96
Microplate Luminometer (Promega) and Tecan GENios fluoro-
meter (GENios; Tecan Germany GmbH, Crailsheim, Germany).
All data were normalized to untreated controls. Cells were treated
with 4 μM caspase-12 inhibitor Z-ATAD-FMK (BioVision) and
caspase-4 inhibitor Z-LEVD-FMK (BioVision) for 48 hours to
inhibit caspase activity.
Analysis of Apoptosis
Flow cytometry was employed for the quantification of apoptosis
in treated cell lines after staining with propidium iodide as described
previously [10]. Analysis of labeled nuclei was performed on an Attune
acoustic focusing cytometer (Applied Biosystems, Carlsbad, CA) and
results were analyzed with the Attune Cytometric Software 1.2.5.3891.
All experiments were performed in triplicates. The percentage of apop-
totic cells was determined by measuring the fraction of nuclei with
a subdiploid DNA content. Ten thousand events were collected for
each sample.
Sample Processing for Transmission Electron Microscopy
HepG2 and Hep3B cells were treated with panobinostat for
48 hours. Control and treated cells were harvested, centrifuged at
1000 rpm for 10 minutes at 4°C, and washed twice with Ca2+/Mg2+-
free phosphate-buffered saline. Cell pellet was suspended in 2.5%
glutaraldehyde 100 mM phosphate buffer (Sörensen’s buffer), incu-
bated for 90 minutes at 4°C, and then centrifuged at 1000 rpm for
10 minutes at 4°C. The pellet was washed twice with Sörensen’s buffer
and then suspended in the same buffer and kept at room temperature
for 7 days. Cell pellet was post-fixed in Sörensen’s buffer for 6 hours at
Figure 1.mRNA expression of ER stress–related factors. Quantitative RT-PCR analysis after 6, 24, 48, and 72 hours of treatmentwith 0.1 μM
panobinostat in HepG2 (A and C) and Hep3B (B and D) cells showing an increase of IRE1α, BiP, ATF4, and CHOP. mRNA expression was
normalized to GAPDH and results are expressed relative to untreated controls set at 1.0. Means ± SD of three independent experiments
performed in triplicates are shown. *P < .05 versus control.
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4°C, rinsed in Sörensen’s buffer overnight, and post-fixed in 1%
osmium tetroxide combined with 1.5% potassium ferricyanide [22]
for 4 hours (4°C). Following dehydration in graded series of ethanol
and propylene oxide, cell pellets were placed in capsules and poly-
merized at 60 and 80°C for 24 hours each. Single or serial silver ultrathin
sections (approximately 70 nm) were cut, mounted on slot grids (oval
hole; Plano, Wetzlar, Germany), and stained with lead citrate and
uranyl acetate. Section thickness was determined using the interference
color of sections floating on water [23] and the minimal folds method
[24]. Ultrathin sections were examined with a Zeiss 906 electron micro-
scope (LEO, Oberkochen, Germany) from 2156 to 35570 magnifica-
tions. Images created with electron microscopy were digitalized with
Agfa SnapScan e50 scanner (Agfa-Gevaert, Mortsel, Belgium) and
adapted for brightness and contrast by Adobe Photoshop 6.0 (Adobe
Figure 2. BiP protein level and localization analysis. (A) Western blot results of BiP in HepG2 (left) and Hep3B (right) cells, treated for 6,
24, 48, and 72 hours with 0.1 μM panobinostat and with 10 nM thapsigargin for 24 hours only. Densitometry results were normalized to
β-actin content and are expressed relative to untreated controls set at 1.0. (B) Immunofluorescence analysis of BiP after 24 and 48 hours
of treatment in HepG2 (upper panel) and Hep3B (lower panel) cells with 0.1 μM panobinostat and 10 nM thapsigargin, showing an increase
and a different protein distribution in panobinostat-treated cells, comparable to 10 nM thapsigargin effect, used as a positive control.
Immunofluorescence analysis has been performed under identical settings. Nuclei were stained with Hoechst 33342. Magnification is
×630, and scale bar represents 10 μm.
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Systems Incorporated, San Jose, CA) software. Black/white plates were
created by using CorelDraw software (CorelDraw version 11; Corel
Corporation, Ottawa, Ontario).
Statistical Analysis
Statistical analysis was performed using SPSS 15.0.1 for Windows
(SPSS Inc, Chicago, IL). The t test and univariate analysis of variance
(ANOVA, Bonferroni procedure) were used to test for differences
between two and more groups of samples, respectively. P < .01 and
P < .05 were regarded as significant.
Results
Panobinostat Induced mRNA Expression of
ER Stress–Related Factors
We have previously demonstrated that HepG2 and Hep3B cells re-
spond significantly to 0.1 μM panobinostat treatment, with a decrease
of cell proliferation and activation of apoptosis that was not mediated
by canonical pathways. Moreover, preliminary results suggested the
involvement of alternative apoptotic pathways, like UPR and ER stress
[10]. On the basis of our previous data, we investigated here the
induction of these pathways in more detail.
First, we analyzed the expression levels of the ER stress–related
factors IRE1α and IRE1β, two isoforms of IRE1, and of the molec-
ular chaperone BiP in both cell lines, after treatment with 0.1 μM
panobinostat from 6 to 72 hours (Figure 1, A and B).
The expression of IRE1α was induced already after 6 hours of treat-
ment with panobinostat in both cell lines and it increased significantly
after 48 hours in HepG2, while it was stable after 72 hours in Hep3B
cells; BiP transcript slightly increased after 6 hours and its level was
almost stable after 48 hours in both cell lines. IRE1β was not expressed
Table 1. Quantification of BiP Immunofluorescence Signals.
Mean SD SEM ANOVA
HepG2
24 hours Control 36.10 7.87 0.22
0.1 μM Panobinostat 54.62 0.80 0.01 0.03
10 nM Thapsigargin 42.20 1.61 0.04 0.15
48 hours Control 11.05 2.94 0.27
0.1 μM Panobinostat 50.35 6.90 0.14 0.00
10 nM Thapsigargin 39.22 5.13 0.13 0.00
Hep3B
24 hours Control 26.67 2.88 0.11
0.1 μM Panobinostat 34.75 6.84 0.20 0.09
10 nM Thapsigargin 42.12 3.67 0.09 0.00
48 hours Control 8.70 3.73 0.43
0.1 μM Panobinostat 26.82 1.84 0.07 0.00
10 nM Thapsigargin 38.02 4.96 0.13 0.00
The immunofluorescence cytosolic signal of BiP shows a significant increase in panobinostat- and
thapsigargin-treated cell lines, especially after 48 hours (P < .05), whereas heterogeneous expression
patterns are observed at the 24-hour time point.
Figure 3. Evaluation of eIF2α protein activation and immunofluorescence analysis for ATF4. Western blot analysis reveals activation
of eIF2α in both HCC cell lines after treatment with 0.1 μM panobinostat for 6, 24, 48, and 72 hours and with 10 nM thapsigargin
for 24 hours. (A) Arrows indicate the specific band for S51-eIF2α. Densitometry results were normalized to β-actin content and are
expressed relative to untreated controls set at 1.0. (B) HepG2 (left panel) and Hep3B (right panel) cells were treated for 24 and 48 hours
with 0.1 μM panobinostat and the immunofluorescence results show an increase of ATF4 and its nuclear localization in both cell lines.
Immunofluorescence analysis has been performed under identical settings. Nuclei were stained with Hoechst 33342. Magnification is
×630, and scale bar represents 10 μm.
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in both cell lines (data not shown). Furthermore, transcription factors
ATF4, which promotes UPR gene expression [14,18], and CHOP, the
best characterized proapoptotic factor related to the ER stress pathway
[25], were analyzed. ATF4 level increased after 48 hours of treatment
with panobinostat in both cell lines but did not reach statistical sig-
nificance. In contrast, CHOP was significantly upregulated starting
already after 24 hours of treatment in both cell lines but decreased to
control level after 72 hours (Figure 1, C and D).
ER stress markers were confirmed to be strongly upregulated after
10 nM thapsigargin treatment, a sarcoplasmic/ER Ca2+-dependent
ATPase pump inhibitor, which was used as positive control of ER
stress induction (Figure W1, A and B).
To confirm our previously published data [10], the effect of pano-
binostat in HepG2 and Hep3B cell lines was compared to thapsigargin
treatment by using the impedance-based real-time cell viability analy-
sis with the xCELLigence System (Figure W1, C and D). Obtained
data revealed that panobinostat caused a reduction of normalized cell
index comparable to the reduction caused by thapsigargin treatment,
confirming that panobinostat induces cell death with an ER stress
resembling mode of action.
Panobinostat Treatment Induced Chaperone Up-regulation
and Attenuation of Protein Translation
We further analyzed the key players of UPR mechanism, to clarify
the exact mechanisms induced by panobinostat treatment in HCC
cell lines. BiP protein level was evaluated by Western blot (Fig-
ure 2A) and by immunofluorescence (Figure 2B) after treatment with
0.1 μM panobinostat and 10 nM thapsigargin. Its level increased
already after 6 hours of treatment in HepG2 cells (2.3-fold increase,
as quantified by densitometric analysis) followed by stabilization until
72 hours. In Hep3B, BiP increased after 24 and 48 hours of treat-
ment (1.6- and 1.4-fold increase; Figure 2A). Thapsigargin treatment
induced the increase of BiP protein level comparable to panobinostat
effects in both cell lines (1.4- and 1.5-fold increase, respectively;
Figure 2A).
The immunofluorescence micrographs, acquired at 24 and 48 hours
of treatment, confirmed the significant increase of BiP in both cell lines,
which was also calculated by immunofluorescence signal quantification
(Table 1). Its increase after treatment with panobinostat was compara-
ble to or moderately stronger than the increase visualized in cells in-
cubated with 10 nM thapsigargin (Figure 2B). Moreover, panobinostat
caused an alteration of BiP cellular distribution, inducing the formation
of brighter aggregate structures in the cytosolic compartment of treated
cells (Figure 2B).
ER stress induced in HCC cells by treatment with panobinostat was
furthermore confirmed by Western blot analysis of eIF2α protein level,
its Ser51-phosphorylated active form, and its target ATF4 (Figure 3,
A and B). eIF2α densitometry analysis showed a stable level in HepG2
until 48 hours of treatment and a 1.7-fold increase in Hep3B after
24 hours of treatment. Interestingly, panobinostat induced an increase
of Ser51-eIF2α after 48 hours in both cell lines (Figure 3A), indicating
the involvement of active eIF2α after DACi treatment. Treatment
with 10 nM thapsigargin induced solely a strong increase of the eIF2α
active form Ser51-eIF2α in both cell lines (Figure 3A).
Immunofluorescence staining of ATF4 after treatment with pano-
binostat showed not only an increase of its expression in both cell lines,
as confirmed by fluorescent signal quantification and by PCR, but also
a strong and significant localization in the nuclear compartment
(Figures 3B and W2 and Table 2), suggesting its translocation to the
nuclei, where it can perform its activity. Additionally, ATF4 protein
expression was evaluated by Western blot in cytosolic and nuclear
fractions (Figure W3A) up to 72 hours of treatment with panobino-
stat, confirming the strong increase of this protein in the nuclear
compartment in both cell lines. Surprisingly, ATF4 protein level
slightly increased also in the cytosolic fraction; thapsigargin induced
the increase of ATF4 in both cellular compartments and in both
cell lines.
Panobinostat Activated IRE1α/XBP-1 Arm of UPR
During ER stress conditions, IRE1α, another essential UPR player,
is activated through autophosphorylation after BiP dissociation.
We further investigated IRE1α protein level and its downstream
target XBP-1. In Figure 4, we show that both IRE1α and its ac-
tive Ser724-phosphorylated form significantly increased in HepG2
(A) and Hep3B (B) cells after 24 and 48 hours of panobinostat treat-
ment and verified this by immunofluorescence signal quantification
(Table 3), confirming the involvement of this factor in UPR activa-
tion mediated by panobinostat. Moreover, we observed that panobino-
stat treatment induced a reorganization of Ser724-phosphorylated
IRE1α, which appeared with a spotted distribution (Figure 4, A
and B; enlargement example depicted for Hep3B after a 24-hour
treatment). IRE1α and its Ser724-phosphorylated form were further
analyzed by Western blot after 72 hours of treatment with panobino-
stat, displaying an increase at 24 and 48 hours in HepG2 cells and
Table 2. Quantification of Cytoplasmic and Nuclear ATF4 Immunofluorescence Signals.
Cytosol Nuclear
Mean SD SEM T Test Mean SD SEM T Test
HepG2
24 hours Control 70.54 6.43 0.09 34.66 6.49 0.19
0.1 μM Panobinostat 66.58 8.33 0.12 0.19 114.82 25.65 0.22 0.00
48 hours Control 101.54 10.05 0.10 12.82 3.03 0.24
0.1 μM Panobinostat 116.67 10.64 0.09 0.03 92.42 16.03 0.17 0.00
Hep3B
24 hours Control 120.75 6.20 0.05 46.85 8.92 0.19
0.1 μM Panobinostat 96.32 8.65 0.09 0.007 94.35 19.64 0.21 0.01
48 hours Control 78.30 5.50 0.07 20.90 5.10 0.24
0.1 μM Panobinostat 79.67 9.96 0.12 0.444 69.73 8.80 0.13 0.00
Quantification of immunofluorescence signals shows a tendentious decrease of cytoplasmic signals between treated and untreated cell lines after 24 hours, whereas a significant increase of nuclear signals is
found in the panobinostat-treated cell lines throughout all time periods (P < .05).
148 Panobinostat Triggers ER Stress in HCC Montalbano et al. Translational Oncology Vol. 6, No. 2, 2013
stable levels in Hep3B cells (Figure W3B); thapsigargin was used as a
positive control.
IRE1α, once active, can catalyze the splicing of XBP-1 to generate
an active transcription factor with higher transactivating activity
[26,27]. Panobinostat treatment was able to induce XBP-1 splicing
already after 6 hours of treatment in both cell lines (Figure 4C). The
spliced form of XBP-1 (XBP-1s) strongly increased after 48 hours
in HepG2, while the unspliced form (XBP-1u) was only reduced in
Figure 4. Analysis of IRE1α/XBP1 involvement. Immunofluorescence results of IRE1α and its phosphorylated form in HepG2 (A) and
Hep3B (B) cell lines after 24 and 48 hours of treatment with 0.1 μM panobinostat. The results indicate that panobinostat induces an
increase of both the total and the phosphorylated form of IRE1α and a spotted distribution of this protein (enlargement showed for
phospho-IRE1α, B). Immunofluorescence analysis has been performed under identical settings. Nuclei were stained with Hoechst
33342. Magnification is ×630, and scale bar represents 10 μm. RT-PCR analysis of total RNA isolated from HepG2 and Hep3B cells
treated with 0.1 μM panobinostat for 6, 24, and 48 hours (C). For this experiment, primers detecting both unspliced (XBP-1u, 442 bp) and
spliced (XBP-1s, 416 bp) forms of XBP-1 mRNA were used. Both cell lines have been treated for 24 hours with 10 nM thapsigargin used
as a positive control. Levels of GAPDH mRNA were used as a control for mRNA concentration.
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Hep3B after 24 and 48 hours of treatment (Figure 4C). Panobinostat
effect was merely comparable to 10 nM thapsigargin effect in HepG2
cells at 48 hours of treatment.
Role of CHOP in Panobinostat-Induced Effects
We, then, investigated a possible involvement of CHOP, a tran-
scription factor triggering cell death in protracted ER stress scenario,
in the mechanism induced by panobinostat treatment. Protein level
of CHOP, analyzed by immunofluorescence, increased significantly
after 24 and 48 hours of treatment in both cell lines (Figure 5A and
W4 and Table 4). Moreover, panobinostat treatment was compara-
ble to or even stronger than thapsigargin inducing a clear nuclear
localization of CHOP (Figure 5A and Table 4).
Furthermore, CHOP protein level, evaluated by Western blot
in cytosolic and nuclear fractions after 72 hours of treatment with
panobinostat, proved the strong increase in the nuclear compartment
and a stable level in the cytosolic fraction of HepG2 cells and its
increase in both fractions of Hep3B cells. Surprisingly, thapsigargin
induced CHOP increase only in the cytosolic fraction of both cell lines
(Figure W3A).
Since panobinostat was able to strongly upregulate CHOP at both
transcriptional (Figure 1, C and D) and translational (Figure 5A)
levels, and since it has been shown that CHOP plays a fundamental
role in mediating apoptosis, we evaluated the effects of CHOP
knockdown on cell viability by using a specific CHOP siRNA
(80% of knockdown efficiency; data not shown) alone and in com-
bination with 0.1 μM panobinostat and analyzed cellular prolifera-
tion with the xCELLigence System. CHOP knockdown did not
recover the cytotoxic effects of panobinostat in both cell lines
(Figure 5B).
ER Stress–Related Cell Death
Sustained or massive ER stress can lead to cell death, and at least
three pathways have been proposed to be involved in ER stress–
mediated apoptosis: CHOP, tumor necrosis factor receptor–associated
factor-2/apoptosis signaling kinase 1/JNK, and caspase-12 activa-
tion [25]. IRE1α activation can result in JNK phosphorylation,
which is then activated and can exert its proapoptotic effects. Our
previous work demonstrated that panobinostat treatment was able
to induce a transient JNK phosphorylation in HepG2 and Hep3B
cell lines [10]. To elucidate JNK involvement in panobinostat-
induced cell death, we used the specific ATP-competitive JNK
inhibitor SP600125 and we evaluated its effect on HCC cellular pro-
liferation alone and in combination with panobinostat. SP600125
alone showed no cytotoxic effects in both cell lines (Figure 6, A and
B) or reverted the effects of panobinostat partially, especially in HepG2
within the first 24 hours of treatment (Figure 6, C and D), indicat-
ing an early involvement of this mitogen-activated protein kinase in
panobinostat treatment response due to the transient increase of its
phosphorylated form [10].
To further elucidate how panobinostat was able to terminally induce
cell death in HCC cells, we analyzed ER stress–related caspase-12
and caspase-4.
Panobinostat induced a significant activation of both caspases (P <
.01) in Hep3B and a slight activation in HepG2 cells (Figure 7, A
and B). The addition of specific caspase-12 and caspase-4 inhibitors
neutralized caspase-12 activation in Hep3B and caspase-4 activation
in both cell lines determined by panobinostat treatment (Figure 7, A
and B). Moreover, the inhibition of caspase-12 reduced panobinostat
effects on cell death in HepG2 cells (Figure 7C ) and the inhibition
of both caspase-12 and caspase-4 led to a slight recovery from
panobinostat-induced cell death in Hep3B (Figure 7D). We have
also investigated the activity of the initiator caspase-8 (Figure 7, C
and D) and the effector caspase-3/7 (Figure 7, E and F ). Interest-
ingly, the inhibition of both caspase-12 and caspase-4 blocked sig-
nificantly caspase-8 activation in both cell lines (P < .01 in both cell
lines with caspase-12 inhibitor and in Hep3B with caspase-4 inhibitor;
Figure 7, C and D).
In addition, induced caspase-3/7 activity after panobinostat treat-
ment was strongly inhibited by caspase-4 inhibitor (P < .01 in both
cell lines with caspase-12 and caspase-4 inhibitors; Figure 7, E and
F ). The results referring to caspase-3/7 activity in Hep3B cells after
addition of 0.1 μM panobinostat and caspase-12 inhibitor have been
already published in our previous work [10].
Panobinostat Induced Altered ER Morphology
The induction of ER stress was also supported by qualitative
ultrastructure analysis using transmission electron microscopy
(TEM). Micrographs of untreated HepG2 and Hep3B cells showed
regular arrangement of ER cisternae distributed randomly through-
out the cytoplasm (Figure 8, A and B, left panel ). After 24 and
48 hours of treatment with 0.1 μM panobinostat, ER cisternae
appeared fragmented and extremely disorganized in both cell lines.
Note the enlargements in Figure 8 (A and B, right panels); the arrows
indicate ER cisternae.
Table 3. Quantification of IRE1α and Ser724-IRE1α Immunofluorescence Signals.
IRE1α S724-IRE1α
Mean SD SEM T Test Mean SD SEM T Test
HepG2
24 hours Control 37.30 8.46 0.23 3.17 0.83 0.26
0.1 μM Panobinostat 61.40 10.56 0.17 0.02 19.02 5.27 0.28 0.00
48 hours Control 26.32 9.16 0.35 4.53 2.27 0.50
0.1 μM Panobinostat 41.87 9.82 0.23 0.09 22.88 4.82 0.21 0.01
Hep3B
24 hours Control 13.22 7.98 0.60 1.75 1.47 0.84
0.1 μM Panobinostat 32.70 6.05 0.18 0.02 35.02 7.60 0.22 0.00
48 hours Control 9.50 4.75 0.50 4.10 2.61 0.64
0.1 μM Panobinostat 16.20 4.35 0.27 0.06 10.53 1.30 0.12 0.01
After treatment with panobinostat, an increase of IRE1α signal is observed in HepG2 and Hep3B cell lines reaching a significant level only after 24 hours (P < .05). For the phosphorylated form
Ser724-IRE1α, a significant increase of this protein is demonstrated during all time points investigated in both cell lines (P < .05).
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Figure 5. (A) Role of CHOP in panobinostat-induced cell death. Immunofluorescence analysis of CHOP after 24 and 48 hours of treat-
ment in HepG2 (upper panel) and Hep3B (lower panel) cells with 0.1 μM panobinostat, showing an increase and the nuclear localization
of CHOP in panobinostat-treated cells, comparable to 10 nM thapsigargin effect used as a positive control. Immunofluorescence analy-
sis has been performed under identical settings. Nuclei were stained with Hoechst 33342. Magnification is ×630, and scale bar represents
10 μm. For the impedance-based real-time cell viability study (B), HepG2 and Hep3B cells were cultured in E-plates and simultaneously
transfected with a specific CHOP siRNA; panobinostat at 0.1 μM was added after approximately 24 hours. Cell index was normalized to
the time point of treatment with panobinostat. Cell index was determined continuously for additional 70 hours. AllStars Negative Control
was included as nonsilencing control. Results are means ± SD from triplicates.
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Discussion
HCC is the fifth most common tumor and the third leading cause
of cancer-related deaths worldwide [28]. HCC is still associated with
poor prognosis and only around 30% of diagnosed patients are con-
sidered eligible for potential curative treatment. The tyrosine kinase
inhibitor sorafenib was the first systemic targeted therapy approved by
the US Food and Drug Administration for the treatment of advanced
HCC despite its limitations, like low overall response rates and high
toxicity [29].
Sustained efforts have been put into discovering new targets
and molecular pathways to develop novel drugs. Since epigenetic
modifications, such as hyperacetylation of histones and nonhistone
proteins, in addition to classic genetic mechanisms, have been dis-
covered to be involved in tumor development and progression,
DACis have been considered as novel attractive therapeutic ap-
proaches for several malignancies [30], including also HCC. DACis
are a heterogeneous class of drugs able to regulate the acetylation
status of diverse intracellular proteins, like histones, transcription
factors, and molecular chaperones [31,32]. The hydroxamic acid
Table 4. Quantification of Nuclear CHOP Immunofluorescence Signals.
Mean SD SEM ANOVA
HepG2
24 hours Control 14.70 4.55 0.31
0.1 μM Panobinostat 99.86 28.07 0.28 0.00
10 nM Thapsigargin 118.72 13.00 0.11 0.00
48 hours Control 5.10 2.64 0.52
0.1 μM Panobinostat 96.52 11.89 0.12 0.00
10 nM Thapsigargin 87.50 6.60 0.07 0.00
Hep3B
24 hours Control 30.65 5.65 0.18
0.1 μM Panobinostat 76.27 11.91 0.16 0.01
10 nM Thapsigargin 55.73 5.77 0.10 0.01
48 hours Control 23.02 5.50 0.24
0.1 μM Panobinostat 114.70 10.84 0.09 0.00
10 nM Thapsigargin 93.75 12.74 0.14 0.00
The nuclear expression of CHOP is significantly higher in panobinostat- and thapsigargin-treated
cell lines (P < .05) compared to controls. Interestingly, the immunofluorescence signal of CHOP
in the nuclei of panobinostat-treated Hep3B cells is significantly higher compared to thapsigargin
treatment used as positive control (P < .05).
Figure 6. Involvement of JNK in panobinostat-induced cell death. HepG2 (A and C) and Hep3B (B and D) cells were cultured in E-plates
and, after approximately 24 hours, treated with 0.1 μM panobinostat and 100 nM and 10 μM SP600125. Cell index was normalized to the
time point of treatment. Cell index was determined continuously for additional 70 hours. In C and D, the effects of the compounds
during the first 24 hours of treatment are depicted, displaying that SP600125 is able to partially recover the early effects of panobinostat
in both cell lines.
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panobinostat (LBH589) is among the most potent DACis, with
nanomolar DAC inhibitory activity and a strong antitumor ability
demonstrated for hematologic and solid malignancies in vitro, in vivo,
and in clinical trials [2,33]. Despite the recent intensive studies on
DACi, the exact mechanisms of action of these compounds are not
completely understood.
It has been shown that through the inhibition of deacetylase activ-
ity, they can affect a broad range of cellular pathways, modulating cell
cycle arrest, cell differentiation, canonical apoptotic pathways, and
alternative cell death mechanisms [33–35]. Furthermore, DACis like
vorinostat and panobinostat are able, solely or in combination with
other drugs, to contribute to UPR and to induce ER stress–mediated
Figure 7. Panobinostat induces ER stress–mediated caspase activation. Caspase-12 (A) and caspase-4 (B) activities were analyzed using
specific fluorimetric assays after treatment of HepG2 and Hep3B cells with 0.1 μM panobinostat and caspase-12 (Z-ATAD-FMK) and
caspase-4 (Z-LEVD-FMK) inhibitors for 48 hours. The percentage of apoptotic cells was determined by measuring the fraction of nuclei with
a subdiploid DNA content after treatment with 0.1 μM panobinostat and caspase-12 (Z-ATAD-FMK) and caspase-4 (Z-LEVD-FMK) inhibitors
for 48 hours (C and D). Caspase-8 activity was analyzed in HepG2 (E) and Hep3B (F) cells using a luminescent assay. Downstream activity of
caspase-3/7, analyzed in HepG2 (G) and Hep3B (H) cells through a luminescent assay, decreases after inhibition of caspase-12 with Z-ATAD-
FMK and of caspase-4 with Z-LEVD-FMK. *P < .05 versus control or #P < .05 versus panobinostat alone; **P < .01 versus control or
##P < .01 versus panobinostat alone.
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apoptosis, for instance through the acetylation of heat shock proteins
like BiP [6,7,10,36,37].
Different physiological and pathologic conditions can compromise
ER functions, leading to the activation of a specific and complex
signaling pathway, named UPR, with following transcriptional up-
regulation of genes encoding molecular chaperones, oxidoreductases,
and ER-associated degradation components [38], in attempt to re-
establish ER homeostasis.
UPR is orchestrated by three distinct stress sensors located at the ER
membrane, IRE1α, PERK, and ATF6α [14], that are kept inactive by
the chaperone BiP under physiologic conditions [10,15]. As a con-
sequence of stress, they dissociate from BiP and transduce the UPR
signal, while the chaperone binds the hydrophobic residues of un-
folded proteins, to facilitate proper protein folding, to prevent protein
aggregate formation, and to drive misfolded proteins to the final pro-
teasomal degradation [39]. However, if stress is protracted and ER
function is severely impaired, the organelle triggers apoptotic cell
death. We have previously shown that panobinostat treatment was
able to induce apoptotic cell death in vitro and in vivo, surprisingly,
without the involvement of canonical pathways [4,10]. Here, we
clearly demonstrate that panobinostat is able to induce alternative
apoptotic cell death in two different HCC cell lines (HepG2 and
Hep3B) through the activation of ER stress pathway. Its modality
of action was comparable to thapsigargin, a sarcoplasmic/ER Ca2+-
dependent ATPase pump inhibitor, used as an ER stress inducer
[40]. In both HCC cell lines, panobinostat treatment induces the
early up-regulation of BiP transcript and the protracted increase of
its protein level, probably due to posttranslational modifications,
e.g., acetylation, which enhances its protein stability [7,36]. In our
model, panobinostat upregulates and induces IRE1α, a transmem-
brane protein harboring a dual enzymatic activity of protein kinase
and endoribonuclease [41]. The endoribonuclease activity is involved
in the processing of XBP-1 mRNA and the Ser/Thr kinase domain
is implicated in the recruitment of tumor necrosis factor receptor–
associated factor-2/apoptosis signaling kinase 1 to mediate the activa-
tion of JNK and of nuclear factor κB [42]. IRE1α, once free from BiP
binding, can be activated through trans-autophosphorylation on
Ser724 [41] and further catalyzes XBP-1 splicing, which is clearly
Figure 8. TEM analysis of ER morphology. HepG2 (A) and Hep3B (B) cells were treated for 24 and 48 hours with 0.1 μM panobinostat
and then processed as described in Materials and Methods section. ER distribution and morphology appear extremely disorganized with
fragmented cisternae in both HCC cells after treatment with panobinostat. This pattern is highlighted by an enlargement of each picture
(inserts). The black arrows indicate the areas of particular interest. Magnification is ×2156 and ×35570, and scale bars represent 5 μm
and 1 μm, respectively.
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detectable in HepG2 after panobinostat treatment. Then, XBP-1s can
induce the expression of several genes involved in different aspects of
UPR [18,26,43], regulating not only the adaptive response to
ER stress but also apoptotic cell death. In LLC-PK1 cells, induction
of CHOP, activation of XBP-1, and phosphorylation of JNK were
identified as possible downstream events responsible for apoptosis
[44]. Moreover, XBP-1 is known to activate the transcription of
CHOP [25]. In Hep3B cells, which differ from HepG2 in being
p53 deficient, XBP-1s is detectable only after 6 hours of panobinostat
treatment, but so far there is no evident correlation between p53
expression and XBP-1 splicing. Further analyses are needed to clarify
this aspect.
Moreover, at high stress signaling levels, IRE1α may contribute to
membrane-associated mRNA degradation through a process named
regulated IRE1α-dependent decay that could first defend cells against
ER stress by limiting new protein translation and further promote
apoptotic mechanism in the setting of severe ER stress [18].
During UPR, an ER resident protein kinase (PERK), phospho-
rylates the α subunit of eIF2α, which alleviates ER stress through
attenuation of global mRNA translation, by decreasing the overload
of misfolded proteins and favoring the expression of ATF4 transcrip-
tion factor [14,18]. Panobinostat treatment leads to eIF2α phos-
phorylation in both HCC cell lines and to ATF4 up-regulation
and nuclear translocation, where it can regulate the expression of
target genes, like CHOP [15].
Additionally, the transcription factor CHOP, one of the pro-
apoptotic members of the ER stress–mediated apoptotic pathway
[25,45], strongly increases after panobinostat treatment in HCC
cells. CHOP promotes the transcription of some BH3-only and
growth arrest and DNA damage–inducible 34 genes and represses
the expression of the antiapoptotic Bcl-2 gene, thus contributing to
the induction of canonical apoptosis [46]. Surprisingly, despite the
ability of panobinostat to upregulate CHOP in HepG2 and Hep3B
cells, this transcription factor is not the key player of panobinostat-
induced cell death in our model, since its specific knockdown is not
able to counteract panobinostat effects. This finding is in line with
our previous results showing that panobinostat affected neither the
mitochondrial potential nor Bcl-2 members’ expression [10].
In addition to CHOP, JNK and caspase activation have also been
implicated in ER stress–mediated apoptosis [15,47]. In particular,
it has been demonstrated that JNK mediates ER stress–related cell
death through the activation of caspase-12, a murine member of the
inflammatory group of caspase family localized in the ER [25,48–50].
Our results using the specific JNK inhibitor SP600125 show that
this kinase is strongly implicated in the early response to panobinostat
treatment, confirming our previously published results about its
transient phosphorylation [10].
Our data suggest that the up-regulation of CHOP, together
with the activation of JNK, contributes to panobinostat-induced
cell death in HCC cell lines through the activation of the ER resi-
dent caspase-12. However, the role of caspase-12 in human is still
under debate, since human caspase-12 gene has a single-nucleotide
polymorphism, which leads either to a truncated protein or to a
full-length protein with no enzymatic activity [50,51]. Moreover,
caspase-4, belonging to the same caspase-12 subfamily, was found
in human to be localized to the ER membrane and activated spe-
cifically by ER stress inducers, showing a caspase-12 identical mecha-
nism of action [49]. Here, we show that panobinostat is able to induce
Figure 9. Schematic representation of panobinostat effects in liver cancer models. Panobinostat is able to inhibit DACs, inducing acetylation
of histones and non-histone proteins, leading to chromatin remodeling and tumor suppressor miRNA up-regulation, both contributing to
block cell proliferation and to induce alternative cell death. In particular, the acetylation of molecular chaperones, like BiP, together with
modulation of ER stress marker expression, triggers an ER stress–mediated cell death, through the involvement of IRE1α/XBP-1/JNK,
eIF2α/ATF4, CHOP, and caspase-12/4, caspase-8, and caspase-3/7.
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caspase-12 and even stronger caspase-4 activation, which in turn
triggers caspase-8 and caspase-3/7, leading to alternative apoptotic
cell death.
Finally, panobinostat treatment induces clear ER morphology
alterations in HepG2 and Hep3B cell lines, confirming ER stress
induction. Indeed, during ER stress, the accumulation of unfolded
proteins and the impairment of ER function can be clearly detected
through morphologically fragmented and disorganized ER cisternae
observed by TEM micrographs [52–54].
In summary, we present for the first time that the pan-DACi
panobinostat causes an ER stress–mediated alternative cell death path-
way in HCC cell lines HepG2 (TP53wt) and Hep3B (TP53null),
through the involvement of BiP, IRE1α/XBP-1, and eIF2α/ATF4
axis, which triggers JNK and CHOP induction that finally acti-
vates caspase-12/4, caspase-8, and caspase-3/7, in a p53-independent
manner (Figure 9). A role in the regulation of ER stress markers
of other p53 family members, i.e., p63 or p73, has been recently
shown [55,56] and cannot be excluded in our setting for panobinostat-
induced effects.
Nevertheless, apoptotic cell death mechanisms under conditions of
irreversible ER damage are only partially understood and may involve
a series of additional complementary pathways [46].
It has been widely demonstrated that autophagy, an evolutionary
conserved intracellular degradation pathway that plays a crucial role
in eliminating long-lived proteins, recycling of cytoplasmic compo-
nents, and removal of damaged organelles, is upregulated in response
to ER stress [57,58]. In particular, the UPR can trigger and regu-
late autophagy at different stages to remove damaged ER [59,60].
Autophagy up-regulation during ER stress is activated to relieve the
stress and to restore homeostasis of the ER. However, prolonged or
unresolved ER stress results in activation of the apoptotic program
[59]. Recent studies provided that panobinostat induces autophagy
in a colon cancer model through the involvement of death-associated
protein kinase 1, a positive regulator of autophagy activated in response
to ER stress [59,61].
Moreover, various studies revealed that miRNAs, like miR-346
[62], miR-708 [63], or miR199a/214 [64], are possible regulators
of cell death during ER stress [17] and that panobinostat, as well
as other HDACis, could trigger the expression of miRNAs related
to ER stress in different models [20,65–67].
Furthermore, panobinostat is able to affect a broad and diverse
spectrum of signaling pathways, like cell cycle progression and cel-
lular proliferation, for instance, through transcriptional regulation
of p21/WAF1 (CDKN1A) [10] and promotion of tumor suppressor
miRNA hsa-let-7b maturation, leading to the inhibition of the
oncogene HMGA2 [20]. The high complexity of panobinostat effects
culminate in cellular proliferation rate decrease and cell death promo-
tion, presenting DACi as a new class of compounds that may sig-
nificantly contribute to overcome the high resistance to treatment
with conventional chemotherapeutic agents. Undoubtedly, additional
analyses are required to elucidate their mechanism of action.
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Supplementary Materials and Methods
Real-time Cell Viability Analysis after Panobinostat and
Thapsigargin Treatment
The xCELLigence RTCA SP System (Roche Applied Science) was
used for real-time and time-dependent analysis of the cellular response
of HepG2 and Hep3B cells following incubation with 0.1 μM pano-
binostat and thapsigargin (10 nM, 100 nM, 1 μM, and 10 μM), as
previously described in Materials and Methods section.
Cytosolic and Nuclear Protein Extraction
Cytosolic and nuclear protein fractions were obtained fromHepG2
and Hep3B cells after 6 to 72 hours of treatment with 0.1 μM pano-
binostat and after 24 hours of treatment with 10 nM thapsigargin, by
using NP-40 lysis buffer [10 mM Tris-HCl, (pH 7.4), 10 mM NaCl,
3 mM MgCl2, 0.5% (vol/vol) NP-40, protease inhibitors (Roche
Applied Sciences)], and with 0.5% Triton X-100 lysis buffer contain-
ing 10 mMTris-HCl, 5 mMMgCl2, and 0.25M sucrose, performing
the previously described protocol [1].
Western Blot Analysis
Whole-cell lysates and cytosolic and nuclear protein fractions were
processed by sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis followed by Western blot analysis, as previously described
[1]. Immunodetection applying primary antibodies against IRE1α,
S724-IRE1α, ATF4, CHOP (Abcam), histone H3 (Active Motif,
La Hulpe, Belgium) as nuclear positive control, and β-actin (Sigma-
Aldrich) as cytosolic positive control was performed. Bound second-
ary HRP-conjugated antibodies (Sigma-Aldrich) were detected by
incubating the immunoblots with SuperSignal West Pico Chemi-
luminescent Substrate (Pierce, Thermo Fisher Scientific). The lumi-
nescent reactivity was measured using Fusion image capture and further
quantified with Bio1D Analysis System (PEQLAB Biotechnologie
GmbH). Anti–histone H3 and anti–β-actin were used to control equal
loading and protein quality.
Supplementary Results
Effects of ER Stress Inducer Thapsigargin on
HCC Proliferation
Thapsigargin concentration was chosen using impedance-based real-
time cell viability analysis with the xCELLigence System (Figure W1,
C and D). These results confirmed previously published data [2] refer-
ring to panobinostat effects in HepG2 (Figure W1C ) and Hep3B
(Figure W1D) cell lines. Panobinostat (0.1 μM) significantly reduced
the normalized cell index in both cell lines and its effect was comparable
to 10 nM thapsigargin treatment, the concentration that was adopted
for the other experiments.
Panobinostat and Thapsigargin Effects on IRE1α
Protein Level Analyzed by Western Blot
IRE1α and its phosphorylated form S724-IRE1α showed an increase
after panobinostat treatment in HepG2, in particular after 48 hours,
whereas stable levels were detectable in Hep3B cells (Figure W3B).
Thapsigargin treatment induced IRE1α and S724-IRE1α increase in
both cell lines.
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Figure W1. Comparison between panobinostat and thapsigargin effects. Quantitative real-time RT-PCR analysis after 6, 24, 48, and 72 hours
of treatment with 10 nM thapsigargin in HepG2 (A) and Hep3B (B) cells showing an increase of IRE1α, BiP, ATF4, and CHOP. mRNA
expression was normalized to GAPDH and results are expressed relative to untreated controls set at 1.0. Means ± SD of three independent
experiments performed in triplicates are shown. *P < .05 versus control. For the impedance-based real-time cell viability study, HepG2
(C) and Hep3B (D) cells were cultured in E-plates and treated with 0.1 μM panobinostat and different concentrations of thapsigargin
(10 nM–10 μM). Cell index was normalized to the time point of treatment. Cell index was determined continuously for additional 70 hours.
Means ± SD of three independent experiments performed in triplicates are shown.
Figure W2. Immunofluorescence analysis of ATF4. The immunofluorescence images in Figure 3B are displayed in separated blue,
green, and merged panels (from left to right) to present ATF4 nuclear translocation after panobinostat treatment in HepG2 and Hep3B
cells. The experiments were performed in triplicates under the same settings.
Figure W3. Western blot analysis of ER stress markers. ATF4 and CHOP protein levels (A) were evaluated after 72 hours of treatment
with 0.1 μM panobinostat and after 24 hours of treatment with 10 nM thapsigargin in HepG2 (left) and Hep3B (right) cell lines, in nuclear
and cytosolic fractions, using histone H3 and β-actin levels as nuclear and cytosolic loading controls, respectively. Arrows indicate the
specific bands for ATF4 and CHOP. Densitometry results were normalized to histone H3 and β-actin contents and are expressed relative
to untreated controls set at 1.0. IRE1α and S724-IRE1α (B) were evaluated after 72 hours of treatment with 0.1 μM panobinostat and
after 24 hours of treatment with 10 nM thapsigargin in HepG2 (left) and Hep3B (right) cell lines in whole-cell lysates. The arrow indicates
the specific band for S724-IRE1α. Densitometry results were normalized to β-actin content and are expressed relative to untreated controls
set at 1.0. Experiments were performed in triplicates.
Figure W4. Immunofluorescence analysis of CHOP. The immunofluorescence images of Figure 5A are displayed in separated blue,
green, and merged panels (from left to right) to present CHOP nuclear translocation after panobinostat and thapsigargin treatment.
Experiments were performed in triplicates under the same settings.
